Free Trial

Moolec Science Q1 2024 Earnings Report

Moolec Science logo
$0.56 0.00 (0.00%)
As of 03:56 PM Eastern

Moolec Science EPS Results

Actual EPS
-$0.04
Consensus EPS
-$0.05
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Moolec Science Revenue Results

Actual Revenue
$1.74 million
Expected Revenue
$0.63 million
Beat/Miss
Beat by +$1.11 million
YoY Revenue Growth
N/A

Moolec Science Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Remove Ads

Moolec Science Earnings Headlines

Moolec Science (NASDAQ:MLEC) Trading Up 5% - Here's Why
Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
Moolec Science Appeals Nasdaq Delisting Notice
See More Moolec Science Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Moolec Science? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moolec Science and other key companies, straight to your email.

About Moolec Science

Moolec Science (NASDAQ:MLEC), a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

View Moolec Science Profile

More Earnings Resources from MarketBeat